麦克森Mckesson（MCK）2026财年第三季度业绩报告「NYSE」（英文版）（17页）.pdf

1、 1 See below under Fiscal 2026 Outlook for full explanation 2 Adjusted results in this earnings release are non-GAAP financial measures;refer to the accompanying definitions and reconciliation schedules McKESSON CORPORATION REPORTS FISCAL 2026 THIRD QUARTER RESULTS AND RAISES FULL YEAR ADJUSTED EPS

2、GUIDANCE IRVING,Texas,February 4,2026-McKesson Corporation(NYSE:MCK)today announced results for the third quarter ended December 31,2025.Third Quarter Highlights:Quarterly consolidated revenues of$106.2 billion increased 11%.Earnings per diluted share of$9.59 increased$2.64.Adjusted Earnings per Dil

3、uted Share of$9.34 increased 16%.Generated$1.2 billion of cash flow from operations and$1.1 billion of Free Cash Flow.McKesson closed the transaction to sell its Norwegian retail and distribution businesses to NorgesGruppen on January 30,2026.Fiscal 2026 Full Year Outlook:Raised and narrowed Adjuste

4、d Earnings per Diluted Share guidance range to$38.80 to$39.20,from the previous range of$38.35 to$38.85.Fiscal 2026 Adjusted Earnings per Diluted Share guidance range indicates 17%to 19%growth compared to the prior year.The Company does not forecast GAAP earnings per diluted share1.“McKesson deliver

5、ed another strong quarter,extending the momentum weve built across the enterprise and demonstrating the impact of our disciplined execution,”said Brian Tyler,chief executive officer.“Our results highlight the strength of our core distribution businesses and the meaningful progress we are making agai

6、nst our strategic priorities.”“Our oncology and multispecialty platforms,together with our expanding suite of biopharma services programs,continue to create differentiated value and deepen the impact for our customers,partners,and patients.The completion of the divestiture of our Norwegian businesse